RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study

RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study

<p>Abstract</p> <p>Background</p> <p>Although Temozolomide is effective against glioblastoma, the prognosis remains dismal and new regimens with synergistic activity are sought for.</p> <p>Methods</p> <p>In this phase-I/II trial, pegylated liposo...

Full description

Bibliographic Details
Main Authors: Proescholdt Martin, Pietsch Torsten, Kölbl Oliver, Jauch-Worley Tanja, Dietmaier Christopher, Brawanski Alexander, Hirschmann Birgit, Steinbrecher Andreas, Grauer Oliver, Beier Dagmar, Kleinletzenberger Christine, Gorlia Thierry, Schmid Christina, Beier Christoph P, Rümmele Petra, Muigg Armin, Stockhammer Günther, Hegi Monika, Bogdahn Ulrich, Hau Peter
Format: Article
Language:English
Published: BMC 2009-09-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/308

Internet

http://www.biomedcentral.com/1471-2407/9/308

Similar Items